Stryker Corp SYK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Stryker Names Spencer Stiles to Succeed Kevin Lobo as CEO
-
Stryker Down Over 7%, On Pace for Largest Percent Decrease Since April 2022 — Data Talk
-
Stryker Stock Declines as Manufacturing Issues Continue
-
Stryker to Acquire ZuriMED
-
Boston Scientific Says Cyberattack Disrupting Global Operations — Update
-
Stryker Down Nearly 8%, On Track for Largest Percent Decrease Since April 2022 — Data Talk
-
Stryker Logs Higher 2Q Profit, Revenue Amid Cyberattack Recovery
-
Stryker Shares Rise After Commercial Launch of Mako Robotic Power System
Trading Information
- Previous Close Price
- €245.10
- Day Range
- €245.10–245.10
- 52-Week Range
- —–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 383.57M
- Market Cap
- $94.01B
- Volume/Avg
- — / 587
Key Statistics
- Price/Earnings (Normalized)
- 20.50
- Price/Sales
- 4.28
- Dividend Yield (Trailing)
- 1.24%
- Dividend Yield (Forward)
- 1.28%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 1.24%
Company Profile
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, mechanical thrombectomy systems, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Large Value
- Total Number of Employees
- 56,000
- Website
- https://www.stryker.com
Competitors
Valuation
|
Metric
|
SYK
|
SNN
|
JNJ
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.50 | 14.07 | 24.07 |
Price/Book Value | 4.48 | 2.22 | 7.41 |
Price/Sales | 4.28 | 1.87 | 6.51 |
Price/Cash Flow | 19.57 | 9.57 | 22.31 |
Price/Earnings
SYK
SNN
JNJ
Financial Strength
|
Metric
|
SYK
|
SNN
|
JNJ
|
|---|---|---|---|
Quick Ratio | 1.08 | 1.11 | 0.73 |
Current Ratio | 2.16 | 2.14 | 1.09 |
Interest Coverage | — | 5.42 | 25.00 |
Quick Ratio
SYK
SNN
JNJ
Profitability
|
Metric
|
SYK
|
SNN
|
JNJ
|
|---|---|---|---|
Return on Assets (Normalized) | 11.44% | 8.51% | 13.42% |
Return on Equity (Normalized) | 23.97% | 17.09% | 32.69% |
Return on Invested Capital (Normalized) | 14.10% | 11.66% | 20.33% |
Return on Assets
SYK
SNN
JNJ
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|@>&%PX | LOCK|wx$Z | $172B | |||
| Medtronic PLC
MDT
| LOCK|$Djfw& | LOCK|#qPV | $113B | |||
| Stryker Corp
SYK
| LOCK|&cmh%gk | LOCK|yt | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|mP%YYk | LOCK|&W#&R | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|#FbF@%g | LOCK|#@?$v | $49B | |||
| DexCom Inc
DXCM
| LOCK|<#@$pY>^ | LOCK|S>!% | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|##pLD%j | LOCK|@K | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|l!D | LOCK|@zC | $24B | |||
| Steris PLC
STE
| LOCK|qwgB!B | LOCK|jr@Yw | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|!tj^zfS | LOCK|G@k | $17B |
United States